NeoGenomics, Inc. (FRA:NG9)
10.20
-0.20 (-1.92%)
Last updated: Jan 29, 2026, 8:04 AM CET
NeoGenomics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 164.12 | 367.01 | 342.49 | 263.18 | 316.83 | 228.71 |
Short-Term Investments | - | 19.83 | 72.72 | 174.81 | 198.56 | 67.55 |
Cash & Short-Term Investments | 164.12 | 386.84 | 415.2 | 437.99 | 515.39 | 296.26 |
Cash Growth | -57.68% | -6.83% | -5.20% | -15.02% | 73.97% | 71.23% |
Receivables | 155.8 | 150.64 | 131.26 | 121.61 | 113.87 | 108.49 |
Inventory | 28.46 | 26.75 | 24.16 | 24.28 | 23.4 | 29.53 |
Prepaid Expenses | 21.99 | 20.17 | 17.99 | 15.24 | 12.35 | 11.55 |
Other Current Assets | 12.11 | 11.62 | 8.2 | 6.18 | 16.5 | 2.91 |
Total Current Assets | 382.47 | 596.02 | 596.81 | 605.29 | 681.51 | 448.73 |
Property, Plant & Equipment | 165.62 | 173.69 | 183.78 | 198.61 | 211.66 | 131.66 |
Long-Term Investments | - | - | - | - | - | 29.56 |
Goodwill | 524.34 | 522.77 | 522.77 | 522.77 | 527.12 | 211.08 |
Other Intangible Assets | 294.16 | 339.68 | 373.13 | 408.26 | 442.33 | 120.65 |
Long-Term Accounts Receivable | - | - | - | 0.03 | 0.24 | 0.29 |
Long-Term Deferred Charges | 0.06 | 0.01 | 0.05 | 0.72 | 0.88 | 0.97 |
Other Long-Term Assets | 8.13 | 5.88 | 4.69 | 4.36 | 6.05 | 45.39 |
Total Assets | 1,375 | 1,638 | 1,681 | 1,740 | 1,870 | 988.33 |
Accounts Payable | 22.61 | 21.61 | 20.33 | 20.51 | 17.92 | 24.97 |
Accrued Expenses | 68.69 | 75.07 | 68.23 | 55.21 | 53.1 | 36.38 |
Current Portion of Long-Term Debt | - | 200.78 | - | 0.07 | 1.14 | 2.84 |
Current Portion of Leases | 4.51 | 3.38 | 5.61 | 6.58 | 6.88 | 4.97 |
Current Unearned Revenue | 1.58 | 0.41 | 2.13 | 7.56 | 5.19 | 4.03 |
Other Current Liabilities | 0.48 | - | - | - | 3 | - |
Total Current Liabilities | 97.87 | 301.24 | 96.3 | 89.93 | 87.23 | 73.18 |
Long-Term Debt | 341.48 | 340.34 | 538.2 | 535.32 | 532.48 | 169.09 |
Long-Term Leases | 64.33 | 60.84 | 67.87 | 68.95 | 72.29 | 42.3 |
Long-Term Unearned Revenue | 0.51 | 0.34 | - | 0.02 | 0.92 | 0.71 |
Long-Term Deferred Tax Liabilities | 20.85 | 21.51 | 24.29 | 34.75 | 55.48 | 5.42 |
Other Long-Term Liabilities | 11.47 | 11.44 | 13.03 | 13.04 | 13.11 | 3.34 |
Total Liabilities | 536.49 | 735.7 | 739.69 | 742.01 | 761.5 | 294.04 |
Common Stock | 0.13 | 0.13 | 0.13 | 0.13 | 0.12 | 0.11 |
Additional Paid-In Capital | 1,262 | 1,228 | 1,190 | 1,161 | 1,124 | 701.36 |
Retained Earnings | -423.93 | -325.78 | -247.06 | -159.09 | -14.84 | -7.19 |
Comprehensive Income & Other | 0.07 | -0.21 | -1.67 | -3.9 | -0.64 | 0.01 |
Total Common Equity | 838.29 | 902.34 | 941.54 | 998.02 | 1,108 | 694.29 |
Shareholders' Equity | 838.29 | 902.34 | 941.54 | 998.02 | 1,108 | 694.29 |
Total Liabilities & Equity | 1,375 | 1,638 | 1,681 | 1,740 | 1,870 | 988.33 |
Total Debt | 410.31 | 605.33 | 611.68 | 610.93 | 612.79 | 219.19 |
Net Cash (Debt) | -246.19 | -218.49 | -196.48 | -172.94 | -97.4 | 77.07 |
Net Cash Growth | - | - | - | - | - | 102.06% |
Net Cash Per Share | -1.93 | -1.73 | -1.57 | -1.39 | -0.81 | 0.69 |
Filing Date Shares Outstanding | 129.39 | 128.46 | 127.61 | 127.46 | 124.03 | 116.94 |
Total Common Shares Outstanding | 128.89 | 128.15 | 127.37 | 126.91 | 124.11 | 112.08 |
Working Capital | 284.6 | 294.78 | 500.51 | 515.36 | 594.28 | 375.55 |
Book Value Per Share | 6.50 | 7.04 | 7.39 | 7.86 | 8.93 | 6.19 |
Tangible Book Value | 19.78 | 39.89 | 45.64 | 67 | 138.84 | 362.56 |
Tangible Book Value Per Share | 0.15 | 0.31 | 0.36 | 0.53 | 1.12 | 3.23 |
Land | - | - | - | - | - | 3.17 |
Buildings | - | - | - | - | - | 7.4 |
Machinery | - | 147.43 | 142.03 | 136.88 | 127.95 | 103.5 |
Construction In Progress | - | 8.51 | 3.61 | 8.98 | 12.4 | 6.29 |
Leasehold Improvements | - | 57.57 | 49.23 | 44.42 | 43.25 | 27.69 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.